Without additional funding from Congress, the U.S. cannot secure sufficient COVID-19 vaccine boosters and variant-specific vaccines for all Americans; reimburse providers to test, treat and vaccinate the uninsured; provide monoclonal antibody therapies to states; or sustain testing capacity, among other actions, according to a White House announcement today. 

“Earlier this month, President Biden laid out a comprehensive plan to ensure that the country can continue to move forward safely and remain prepared to fight new variants and future surges of the virus. And the Administration has been clear that we need Congress to provide additional resources, including $22.5 billion in immediate emergency funding. Inaction will set us back in this fight, leave us less prepared, and cost us more lives,” the fact sheet states.
 

Related News Articles

Chairperson's File
Public
One of the most rewarding parts of being an AHA member and serving on the board is building relationships with other leaders who share a passion for making…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA Dec. 11 expressed support for the reintroduction of the Future Advancement of Academic Nursing, bicameral legislation that would increase nursing…
Headline
The Centers for Medicare & Medicaid Services released guidance Dec. 8 for states implementing Medicaid community engagement requirements outlined by the…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…